(Q28165684)

1

0 references

Emilia Lubart

2

0 references

Arthur Leibovitz

3

0 references

Beni Habot

5

0 references

Michael Yaron

6

0 references

Dan Caspi

full work available at URL

7

0 references

language of work or name

English

0 references

publication date

15 October 2003

0 references

https://api.elsevier.com/content/article/PII:S0002934303004364?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00436-4

https://api.elsevier.com/content/article/PII:S0002934303004364?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00436-4

American Journal of Medicine

22 March 2024

published in

0 references

volume

115

0 references

issue

6

0 references

page(s)

462-6

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Adverse effects of low-dose aspirin in a healthy elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Therapeutic uses of aspirin in renal diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Aspirin-induced depression of renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Membranoproliferative Glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Improvement of renal function with selective thromboxane antagonism in lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

Does aspirin cause acute or chronic renal failure in experimental animals and in humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900436-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Stroke diagnosis and management

3

1 reference

https://api.crossref.org/works/10.1016/S0002-9343(03)00436-4

22 March 2024

Identifiers